Professor Claire Lewis
Clinical Medicine, School of Medicine and Population Health
Professor of Molecular & Cellular Pathology
+44 114 215 9012
Full contact details
Clinical Medicine, School of Medicine and Population Health
Floor E
The Medical School
Beech Hill Road
91Ö±²¥
S10 2RX
- Profile
-
For enquiries please contact - ClinMed-Operational@sheffield.ac.uk
After completing my DPhil (PhD) in the Department of Physiology, Anatomy and Genetics in Oxford in 1986, I held two postdoctoral positions and a Lectureship in the Medical School there before moving to join the Medical School in 91Ö±²¥ in 1996. I currently hold a Personal Chair in Molecular & Cellular Pathology and head a team of pre and postdoctoral scientists.
I was awarded a DSc by Oxford University in 2006 for my contribution to the field of tumour inflammation research. During my career, my group has filed numerous patent applications and worked with various collaborators in the commercial sector. I also enjoyed running a spin-out company and was delighted to receive Cancer Research Horizon's Woman Entrepreneur Award in 2022.
- Research interests
-
Our research is focused mainly on the role of inflammatory cells called macrophages in tumour progression and responses to conventional anti-cancer treatments like chemotherapy and irradiation.
We have also developed ways of using these cells to target therapeutic genes and viruses to tumours. Our work was reported in the national press (,) and is mainly funded by grants from Breast Cancer Now, Prostate Cancer UK, The European Union, Cancer Research UK and Team Verrico.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Journal for ImmunoTherapy of Cancer, 12(7).
- . Nature Communications, 15.
- . Frontiers in Immunology, 14.
- . Future Pharmacology, 2(4), 444-459.
- . Nanomedicine: Nanotechnology, Biology and Medicine, 40.
- . Cancer Research, 81(21), 5399-5400.
- . Biomaterials, 198, 180-193.
- . Nature Cell Biology, 21(2), 190-202.
- . Cancer Research, 78(19), 5492-5503.
All publications
Books
Journal articles
- . Journal for ImmunoTherapy of Cancer, 12(7).
- . Nature Communications, 15.
- . Frontiers in Immunology, 14.
- . Future Pharmacology, 2(4), 444-459.
- . Nanomedicine: Nanotechnology, Biology and Medicine, 40.
- . Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A867-A867.
- . Cancer Research, 81(21), 5399-5400.
- . Biopreservation and Biobanking, 19(4), 324-331.
- . Mol Cancer Ther.
- . Oncogene, 38(28), 5670-5685.
- . Biomaterials, 198, 180-193.
- . Nature Cell Biology, 21(2), 190-202.
- . Cancer Research, 78(19), 5492-5503.
- . Nature Reviews Immunology, 18(11), 689-702.
- . Cancer Cell, 30(1), 18-25.
- . Cancer Research, 75(17), 3479-3491.
- . Nature Communications, 6.
- . Oncotarget, 5(24), 12472-12508.
- , 5(24).
- . Journal of Aging Science, 2(1).
- . Angiogenesis, 17(1), 207-219.
- . CANCER CELL, 23(3), 277-286.
- . Cancer Res, 73(2), 490-495.
- . BIO-PROTOCOL, 3(13).
- . Genesis, 51(1), 41-49.
- CANCER Macrophages limit chemotherapy. NATURE, 472(7343), 303-304.
- . Cancer Research, 71(8_Supplement), 2849-2849.
- . Cancer Res, 71(8), 2826-2837.
- . Cancer Cell, 19(4), 431-433.
- . J Clin Invest, 121(5), 1969-1973.
- . J Immunol, 186(7), 4183-4190.
- . Cancer Res, 71(5), 1805-1815.
- . Int J Cancer, 129(4), 847-858.
- . Journal of Tissue Engineering and Regenerative Medicine, 5(5), 363-374.
- . Cancer Res, 70(13), 5270-5280.
- . J Leukoc Biol, 88(5), 877-884.
- . Am J Pathol, 176(4), 1564-1576.
- . Br J Cancer, 102(3), 594-601.
- . Int J Exp Pathol, 90(3), 222-231.
- . Blood, 114(4), 844-859.
- . Biochim Biophys Acta, 1796(1), 11-18.
- . Gene Ther, 16(3), 329-339.
- . BLOOD, 113(14), 3139-3146.
- . Stroke, 40(2), 369-375.
- . Immunobiology, 213(9-10), 899-908.
- . Nat Rev Cancer, 8(8), 618-631.
- . Gene Ther, 15(12), 902-910.
- . CANCER LETT, 265(2), 239-249.
- Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms. J IMMUNOL, 180(4), 2011-2017.
- . Neoplasia, 10(4), 329-339.
- Research alert: Gene therapy - Microscopic magnets attached to human cells offer hope for cancer treatment. Biomedical Materials(JUNE), 10.
- . Neuropathol Appl Neurobiol, 33(6), 670-683.
- . TRENDS IMMUNOL, 28(12), 519-524.
- . Angiogenesis Assays: A Critical Appraisal of Current Techniques.
- . Cancer Res, 67(18), 8429-8432.
- . Breast Cancer Res, 9(3), 209.
- . J Immunol, 178(11), 7405-7411.
- . Neuropathol Appl Neurobiol, 33(4), 410-419.
- . J Thromb Haemost, 5(4), 846-854.
- . B MATH BIOL, 69(5), 1747-1776.
- . Cancer Research, 66(23), 11238-11246.
- . Stroke, 37(6), 1391-1398.
- . Cancer Res, 66(2), 605-612.
- . J Neuropathol Exp Neurol, 65(1), 26-36.
- . Bioessays, 28(1), 84-94.
- . Prostate, 66(5), 470-494.
- . Br J Cancer, 94(1), 101-107.
- . J Cell Mol Med, 9(2), 286-302.
- . J Immunol, 175(10), 6257-6263.
- . Int J Cancer, 117(5), 701-708.
- . NEUROGENETICS, 6(2), 101-104.
- . J Theor Biol, 232(4), 523-543.
- . The American Journal of Pathology, 167(3), 627-635.
- . Int J Exp Pathol, 85(5), 233-248.
- . Microcirculation, 11(6), 552-553.
- . Microcirculation, 11(6), 531-532.
- . Neuropathology and Applied Neurobiology, 30(5), 427-446.
- . Blood, 104(8), 2224-2234.
- . J THEOR BIOL, 226(4), 377-391.
- . Blood, 103(2), 601-606.
- . ARTHRITIS RHEUM, 50(1), 291-296.
- . BLOOD, 103(5), 1876-1882.
- . Expert Opin Biol Ther, 3(7), 1105-1120.
- . J Natl Cancer Inst, 95(22), 1660-1673.
- . Am J Pathol, 163(4), 1233-1243.
- Mathematical modelling of comedo ductal carcinoma in situ of the breast. MATH MED BIOL, 20(3), 277-308.
- . J MATH BIOL, 47(5), 424-452.
- . B MATH BIOL, 65(4), 609-640.
- . Br J Cancer, 87(10), 1173-1181.
- Expression of hypoxia inducible factor-1 in metastatic tumour's in ovarian cancer: link with p53 expression and relevance to hypoxia-targeted gene therapies for disseminated disease. J PATHOL, 198, 5A-5A.
- Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J LEUKOCYTE BIOL, 72(3), 417-428.
- . J MATH BIOL, 45(2), 125-152.
- . Br J Cancer, 86(11), 1813-1816.
- . J Pathol, 196(3), 254-265.
- . J Pathol, 196(2), 204-212.
- . Journal of Theoretical Medicine, 4(1), 21-39.
- Modelling the interactions between tumour cells and a blood vessel in a microenvironment within a vascular tumour. EUR J APPL MATH, 12, 529-556.
- Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors.. J Leukoc Biol, 70(4), 478-490.
- Hypoxic macrophages accumulate in avascular, hypoxic areas of prostate cancer and benign prostatic hyperplasia.. J PATHOL, 195, 33A-33A.
- . Journal of Interferon & Cytokine Research, 21(9), 757-762.
- . Angiogenesis, 4(2), 113-121.
- Estimating the selective advantage of mutant p53 tumour cells to repeated rounds of hypoxia. B MATH BIOL, 63(1), 135-166.
- . Angiogenesis, 4(4), 269-275.
- Expression of hypoxia-inducible factor la by macrophages in the rheumatoid synovium - Implications for targeting of therapeutic genes to the inflamed joint. ARTHRITIS RHEUM, 44(7), 1540-1544.
- Macrophages accumulate in avascular, hypoxic areas of prostate tumours: implications for targeted therapeutic gene delivery to such sites.. J PATHOL, 192, 8A-8A.
- The role of p53 gene status in modulating the effects of hypoxia on human epithelial ovarian cancer cells. J PATHOL, 192, 10A-10A.
- Macrophage expression of urokinase receptors correlates with macrophage infiltration and angiogenesis in invasive carcinoma of the breast: Regulation by hypoxia. J PATHOL, 192, 20A-20A.
- Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.. Cancer Res, 60(17), 4719-4724.
- Characterisation of hypoxia responsive element activity under anoxia in breast cancer cells: Role of HIF-1 and ATF-4. BRIT J CANCER, 83, 11-11.
- Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J PATHOL, 190(4), 430-436.
- . Gene Therapy, 7(3), 255-262.
- Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas.. J Pathol, 192(2), 150-158.
- . J Leukoc Biol, 66(6), 889-900.
- Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. BRIT J CANCER, 79(5-6), 991-995.
- . Nature Biotechnology, 17(S4), 38-38.
- Regulation of angiogenesis in ovarian cancer: role of p53, vascular endothelial growth factor and hypoxia.. J PATHOL, 189, 16A-16A.
- Expression of vascular endothelial growth factor by macrophages is upregulated in poorly vascularised areas of breast carcinomas. J PATHOL, 189, 13A-13A.
- Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium. J PATHOL, 185(4), 402-408.
- Association of tumour necrosis factor and its receptors with thymidine phosphorylase expression and metastasis in human breast cancer. J PATHOL, 182, A16-A16.
- . Mol Pathol, 51(2), 55-61.
- Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. BRIT J CANCER, 77(12), 2246-2251.
- . The Journal of Pathology, 180(4), 407-414.
- Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research, 56(20), 4625-4629.
- . The Journal of Pathology, 172(3), 229-235.
- . Journal of Leukocyte Biology, 56(4), 423-435.
- . Journal of Immunological Methods, 167(1-2), 47-54.
- . Br J Cancer, 70(2), 289-292.
- . The Journal of Pathology, 169(2), 191-201.
- . The Lancet, 342(8864), 148-149.
- . Br J Cancer, 67(2), 290-296.
- . Cytokine, 5(2), 169-172.
- . Cytokine, 4(1), 63-65.
- . Immunological Reviews, 119(1), 23-39.
- . Cytokine, 3(3), 184-188.
- . Cellular Immunology, 132(1), 158-167.
- . Br J Cancer, 64(3), 457-462.
- . Journal of Immunological Methods, 127(1), 51-59.
- . Journal of Hepatology, 10(1), 90-98.
- Differential effects of LPS, IFN-γ and TNFα on the secretion of lysozyme by individual human mononuclear phagocytes: Relationship to cell maturity. Immunology, 69(3), 402-408.
- . European Journal of Immunology, 19(11), 2037-2043.
- . Journal of Molecular Endocrinology, 2(1), 55-63.
- . Molecular and Cellular Endocrinology, 57(1-2), 41-49.
- . The Lancet, 330(8565), 966-966.
- . The Lancet, 330(8553), 231-234.
- . Neuroendocrinology, 43(5), 584-589.
- . Journal of Endocrinology, 111(3), 483-NP.
- . Journal of Endocrinology, 109(1), 35-NP.
- . Journal of Endocrinology, 106(2), 211-NP.
Chapters
- Alphastatin: a pluripotent inhibitor of activated endothelial cells In Siemann DW (Ed.), Vascular-targeted therapies in oncology (pp. 205-220). Wiley-Blackwell
- , Cytokine Cell Biology (pp. 147-171). Oxford University PressOxford
Conference proceedings papers
- . Cancer Research, Vol. 81(13_Supplement) (pp 2797-2797)
- . Cancer Research, Vol. 81(13_Supplement) (pp 2720-2720)
- Changes in the phenotype of macrophages and CD8+T Cells in the perivascular niche of prostate tumours following androgen deprivation.. CANCER RESEARCH, Vol. 81(13)
- Perivascular accumulation of immunosuppressive cells in the stroma of human triple negative breast carcinomas: implications for immunotherapy.. CANCER RESEARCH, Vol. 81(13)
- . Cancer Research, Vol. 79(13_Supplement)
- . Tumor Biology
- . Journal of Clinical Oncology, Vol. 33(15_suppl) (pp e14035-e14035)
- Microenvironmental signals regulating the tumour-promoting functions of macrophages: role of hypoxia and necrotic debris. JOURNAL OF LEUKOCYTE BIOLOGY (pp 56-56)
- Molecular markers of tissue hypoxia and glial pathology associated with incidental white matter lesions in the ageing brain. BRAIN PATHOLOGY, Vol. 16 (pp S92-S92)
- Engineering macrophages to synthesize recombinant adenoviruses in hypoxic areas of human prostate tumors. CANCER RESEARCH, Vol. 66(8)
- . Journal of Leukocyte Biology, Vol. 57(5) (pp 747-751)
- REGULATION OF BREAST-CANCER CELL-GROWTH BY TGF-BETA, IFN-GAMMA, IL6 AND IL4. JOURNAL OF PATHOLOGY, Vol. 163(2) (pp A170-A170)
Preprints
- Research group
-
Group Members
- Professor Claire Lewis
- Dr Mohammed Ridha (Postdoc)
- Dr Haider Al-Janabi (Postdoc)
- Katy Moyes (Postgraduate RA)
- Richard Allen (PhD student)
- Teaching interests
-
- Acute and chronic inflammation
- Angiogenesis in human diseases
- Cancer
- Professional activities and memberships
-
Journals
- Member of the Editorial Board, Frontiers in Immunology.
- Member of the Editorial Board, Cancer Research.
- Member of the Editorial Board, Cancers.
- Member of the Editorial Board, Journal of Clinical Investigation Insight.
- Member of the Editorial Board, OncoImmunology.
- Member of the Editorial Board, International Journal of Cancer.
- Associate Editor, International Journal of Experimental Pathology.
Grant Awarding Bodies
- Member, MRC/NIHR UK-US Cancer Skills Development Panel (2023 - present).
- Member, MRC Molecular & Cellular Medicines Board (2018-2022).
- Member, PCUK Research Advisory Committee (2019-2022).
- Member, Quinquennial Review Panel, MRC Human Immunology Unit, Oxford, Nov. 2016.
- Member, Quinquennial Review Panel, Breast Cancer Now Manchester Research Unit, Feb. 2016.
- Member, Senior Investigator Awards Committee, The Wellcome Trust, (2013).
- Member of 3 Scientific Advisory Boards: ‘Cancer Immunotherapy’, Tumour Inflammation’ and ‘Metastasis’ for the Cancer Section of EU Framework 7 (2007- present).
- Member, International Science Evaluation Panel (for biology, medicine and health), The Research Council, Norway (2011).
- Member, AACR Basic Cancer Research Grants Scientific Review Committee (2010).
- Chair, BBSRC Review Panel in Interdisciplinary Research (2005).
- MRC College of Experts - Molecular and Cellular Medicine Board, (2004-current).
- EPSRC Peer Review College (2006-2009).
- Member, Scientific Advisory Board, Breast Cancer Campaign (1999-2002).